To further explore survival relationships between tumor NOS2 and COX2 expression relative to T cells, PD1, PDL1, and FOXP3 immunosuppressive markers, we evaluated the ratios of the percentage of cells expressing each marker to tumor NOS2 or COX2. The gene discussed is FOXP3; the disease is neoplasm.